Development Pipeline

Today, our research efforts are dedicated to advancing a diverse pipeline of innovative therapies for solid tumors and blood-related cancers.
Learn about our development programs by selecting an agent below or click to explore our interactive pipeline.

Enfortumab vedotin

an antibody–drug conjugate being investigated in urothelial carcinoma and other solid tumors

  • Phase 1
  • Phase 2
  • Phase 3

View Program